BeStock  
Stocks › AVTX

Avalo Therapeutics AVTX

US equityMarket cap rank #3479
$13.58 −$0.01 (-0.07%)
Pre-market · Oct 8, 8:20 am ET · After hours $13.58 0.00%
Open$13.43
Prev close$13.59
Day range$13.30 – $13.98
Volume719.0K
Market cap$728.30M
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts5
Average target$46.20+240.2% vs. price
  • Buy 100%
Low $30.00Now $13.58Avg $46.20High $60.00

Recent rating changes

The last 20 actions on file set price targets from $30.00 to $62.00, averaging $47.05.

DateFirmRatingTarget
1 Oct 2026 Piper Sandler BUY $60.00
7 Aug 2026 BofA Securities BUY $35.00
7 Aug 2026 H.C. Wainwright BUY $30.00
6 Aug 2026 BTIG BUY $58.00
6 Aug 2026 Guggenheim BUY $48.00
6 Jul 2026 Leerink Partners BUY $38.00
12 Jun 2026 BofA Securities BUY $35.00
11 Jun 2026 TD Cowen BUY –
15 May 2026 Stifel BUY $39.00
14 May 2026 Mizuho Securities BUY $45.00
14 May 2026 Wedbush BUY $34.00
14 May 2026 Citizens JMP BUY $55.00
14 May 2026 H.C. Wainwright BUY $35.00
13 May 2026 BTIG BUY $58.00
11 May 2026 Piper Sandler BUY $60.00
6 May 2026 BTIG BUY $58.00
6 May 2026 Citizens JMP BUY $62.00
6 May 2026 Stifel BUY $36.00
6 May 2026 Guggenheim BUY $50.00
5 May 2026 BTIG BUY $58.00

Discussion

No comments yet — be the first to weigh in on AVTX.

Leave a comment

Scroll to Top